Search results for "Smoking Cessation"


 
Results 1 - 10 of about 140 for "Smoking Cessation".
Sort by: Relevance | Newest | Oldest

Increased doses of smoking cessation therapy improved quit rates following treatment failure

Raising doses of varenicline or nicotine replacement therapy increased abstinence rates in patients for whom an initial dose of varenicline or combined nicotine replacement therapy was ineffective, a two-part trial found.
https://immattersacp.org/weekly/archives/2024/05/07/2.htm
7 May 2024

Presurgery planning may boost postop outcomes

Deconditioning after surgery can happen very quickly, within 24 to 48 hours, but prehabilitation can target modifiable factors to help patients optimize fitness and improve recovery.
https://immattersacp.org/archives/2024/07/presurgery-planning-may-boost-postop-outcomes.htm
1 Jul 2024

Likelihood of smoking cessation after cardiovascular event varies by event type

Patients who had had a myocardial infarction, coronary artery bypass grafting, stroke, or transient ischemic attack were more likely to quit smoking than those who underwent elective percutaneous coronary intervention or had a new diagnosis of peripheral artery disease.
https://immattersacp.org/weekly/archives/2024/02/13/4.htm
13 Feb 2024

Making smoking cessation less of a struggle

This month's issue considers smoking cessation, helping patients with disabilities, and conference coverage from the Society of Hospital Medicine's annual meeting.
https://immattersacp.org/archives/2022/06/making-smoking-cessation-less-of-a-struggle.htm
1 Jun 2022

Repeated tobacco screening linked to higher likelihood of smoking cessation treatment

The average adjusted predicted probability of prescription and/or referral for smoking cessation rose from 13.7% among current and former smokers screened once to 41.7% among those screened five or six times, a study of Veterans Affairs primary care clinics found.
https://immattersacp.org/weekly/archives/2023/06/13/4.htm
13 Jun 2023

Cytisinicline shows promise for smoking cessation in industry-funded trial

In a phase 3 randomized controlled trial, both six- and 12-week courses of cytisinicline, an investigational drug, led to higher rates of continuous smoking abstinence compared with placebo.
https://immattersacp.org/weekly/archives/2023/07/18/1.htm
18 Jul 2023

Take a team approach to coronary disease

A major update to a cardiology guideline puts team-based, patient-centered care at the forefront of management and highlights the role of healthy diet and exercise habits in reducing cardiovascular risk.
https://immattersacp.org/archives/2024/02/take-a-team-approach-to-coronary-disease.htm
1 Feb 2024

Adding nicotine replacement therapy to varenicline monotherapy didn't increase smoking cessation

In a randomized trial of 1,251 adults who smoked five or more cigarettes per day, neither varenicline plus a nicotine patch nor extended-duration treatment was superior to 12 weeks of varenicline monotherapy for abstinence.
https://immattersacp.org/weekly/archives/2021/10/26/2.htm
26 Oct 2021

ATS guideline strongly recommends varenicline for smoking cessation

A new clinical practice guideline from the American Thoracic Society (ATS) made five strong recommendations and two conditional recommendations regarding medications to treat adults with tobacco dependence.
https://immattersacp.org/weekly/archives/2020/07/21/3.htm
21 Jul 2020

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/03/latest-updates-on-acps-priorities-initiatives.htm
1 Mar 2024

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next